GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Lumos Diagnostics Holdings Ltd (ASX:LDX) » Definitions » EV-to-Revenue

Lumos Diagnostics Holdings (ASX:LDX) EV-to-Revenue : 2.41 (As of May. 23, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Lumos Diagnostics Holdings EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Lumos Diagnostics Holdings's enterprise value is A$29.49 Mil. Lumos Diagnostics Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was A$12.25 Mil. Therefore, Lumos Diagnostics Holdings's EV-to-Revenue for today is 2.41.

The historical rank and industry rank for Lumos Diagnostics Holdings's EV-to-Revenue or its related term are showing as below:

ASX:LDX' s EV-to-Revenue Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: 2.41

ASX:LDX's EV-to-Revenue is ranked better than
60.36% of 222 companies
in the Medical Diagnostics & Research industry
Industry Median: 3.29 vs ASX:LDX: 2.41

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-23), Lumos Diagnostics Holdings's stock price is A$0.038. Lumos Diagnostics Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.04. Therefore, Lumos Diagnostics Holdings's PS Ratio for today is 0.95.


Lumos Diagnostics Holdings EV-to-Revenue Historical Data

The historical data trend for Lumos Diagnostics Holdings's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lumos Diagnostics Holdings EV-to-Revenue Chart

Lumos Diagnostics Holdings Annual Data
Trend Jun22 Jun23
EV-to-Revenue
1.71 0.84

Lumos Diagnostics Holdings Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial - - - - -

Competitive Comparison of Lumos Diagnostics Holdings's EV-to-Revenue

For the Diagnostics & Research subindustry, Lumos Diagnostics Holdings's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lumos Diagnostics Holdings's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Lumos Diagnostics Holdings's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Lumos Diagnostics Holdings's EV-to-Revenue falls into.



Lumos Diagnostics Holdings EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Lumos Diagnostics Holdings's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=29.488/12.25
=2.41

Lumos Diagnostics Holdings's current Enterprise Value is A$29.49 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Lumos Diagnostics Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was A$12.25 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lumos Diagnostics Holdings  (ASX:LDX) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Lumos Diagnostics Holdings's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.038/0.04
=0.95

Lumos Diagnostics Holdings's share price for today is A$0.038.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was A$0.04.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lumos Diagnostics Holdings EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Lumos Diagnostics Holdings's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Lumos Diagnostics Holdings (ASX:LDX) Business Description

Traded in Other Exchanges
Address
2724 Loker Ave West, Carlsbad, CA, USA, 92010
Lumos Diagnostics Holdings Ltd is engaged in the development, manufacture and distribution of point-of-care diagnostic (POC) tests and associated readers for analysis of POC diagnostic tests. It also directly develops, manufactures and commercializes proprietary, Lumos-branded POC tests that target infectious and inflammatory diseases. It generates maximum revenue from the commercial services and solutions relating to POC diagnostic tests.

Lumos Diagnostics Holdings (ASX:LDX) Headlines

No Headlines